HeadlineShine

The FDA wants to pull its approval of a drug. It’s not so easy.

Ars Technica ·First reported
Ars TechnicaThe FDA wants to pull its approval of a drug. It’s not so easy.
Image: Ars Technica

The regulator says Tavneos was approved on the basis of manipulated study data. Should patients still have access to it?

Summary from Ars Technica

Read the full story on Ars Technica
React

Trending now

ABC News
5 sources·

1 dead, 6 injured in shooting at California Halloween store, police say
TechCrunch
Business9 sources·

How Binance’s $6.3 Billion Hack Went Down
The Hollywood Reporter
Entertainment11 sources·

'Star Trek' actor Patrick Stewart dies at 86
Yahoo Sports
Sports3 sources·

Titans trade Jeffery Simmons to the Bears

More tech

See all →
TechCrunch
Tech6 sources·

Hackers expose the identities of more than 40,000 DHS employees
CBS News
Tech3 sources·

Meteorite found in the Sahara Desert turns out to be piece of Mars
CNBC
TechCNBC·

Humans are still doing the work behind some AI agents
The Verge
TechThe Verge·

Here’s why you can’t shake those unhinged political texts
The Verge
TechThe Verge·

Touchscreens everywhere!
Ars Technica
TechArs Technica·

Seabirds racing home over the ocean can get jet-lagged

Top stories in the United States

See all →
Yahoo Sports
Sports3 sources·

Philip Rivers emerges as ‘focus’ of NC State’s coaching search
Fox News
Entertainment5 sources·

Selma Blair apologizes to the ‘people that I disappointed’ after plane incident arrest
Yahoo Sports
Sports2 sources·

UFC Fight Night 292: Down the middle on Renato Moicano vs. Tom Nolan
ESPN
Sports10 sources·

When is next World Series game? Brewers vs. Rays schedule
NPR
2 sources·

Questions still haunt Houdini’s Halloween death 100 years later
Fox News
Sports3 sources·

Mammoth Get Nikita Kucherov From Lightning in Trade Pitch Idea